Ayyan Investment Company

Equities

2140

SA0007879261

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
20.56 SAR +0.29% Intraday chart for Ayyan Investment Company -3.29% +31.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ayyan Investment Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Ayyan Investment Posts Bigger FY23 Loss; Revenue Up MT
Saudi Exchange Suspends Eight Companies From Trading Over Regulatory Noncompliance MT
Ayyan Investment Appoints Financial Adviser for Share Exchange Deal with Dallah Healthcare MT
Dallah Healthcare Company signed of a non-binding memorandum agreement to acquire 97% stake in Al-Ahsa Medical Services Company and 100% stake in Al-Salam Medical Services Company from Ayyan Investment Company. CI
Ayyan Investment Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Ayyan Investment Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Ayyan Investment Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ayyan Investment Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ayyan Investment Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Ayyan Investment Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Ayyan Investment Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Ayyan Investment Company Announces Board Changes CI
Ayyan Investment Company Announces the Latest Developments Regarding the Acquisition Deal as Well as the Trial Operation of Al Salam Hospital CI
Ayyan Investment Company Approves Executive Changes CI
Ayyan Investment Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ayyan Investment Company Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Ayyan Investment Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Ayyan Investment Company Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Ayyan Investment Company Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Ayyan Investment Company signed an agreement to acquire a 26.43% stake in Al-Ahsa Medical Services Company from Al Othman Holding Company, Saad Abdulaziz Al Hussein and Sons Company, Ibrahim Abdullah Al Afaleq and Sons Company and Abdul Rahman Saad Al-Rashid and Sons Co. Ltd. for approximately SAR 150 million. CI
Ayyan Investment Company Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Ayyan Investment Company Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Ayyan Investment Company(SASE:2140) added to S&P Global BMI Index CI
Ayyan Investment Company Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Chart Ayyan Investment Company
More charts
AYYAN Investment Co. SJSC, formerly Al-Ahsa Development Co. SJSC, is a Saudi Arabia-based company, primarily engaged in general construction of non-residential buildings including schools, hospitals, hotels etc. The main activities of the Group are categorized into three main business sectors, the medical services sector which focuses on establishing, maintenance and operating hospitals, medical centers, government and private dispensaries; the manufacturing sector specializes in production of dates , derivatives manufacturing , establishing cold stores , wholesaling and retailing in food products Company specializing in the production and packaging of dates; and Investment sector includes industrial investment, service investment, investing in securities, real estate investment and medical investment. The Company operates approximately four subsidiaries.
More about the company
  1. Stock Market
  2. Equities
  3. 2140 Stock
  4. News Ayyan Investment Company
  5. Ayyan Investment Appoints Financial Adviser for Share Exchange Deal with Dallah Healthcare